Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-11-24
pubmed:abstractText
Aim of the present study was to evaluate in vitro toxicity and in vivo antibacterial, anti-inflammatory, antiulcer, and antioxidant activities of two organoselenium compounds, selenocystine (SeCys) and ebselen (Ebs). The study was conducted in experimentally induced ulcers in rodent model infected with Helicobacter pylori (H. pylori). In vitro toxicological studies on normal splenic lymphocytes revealed that SeCys and Ebs were non-toxic to the cells even at 100 ?M concentration. Antibacterial activity was observed at 500 ?g/mL concentration of either of the compounds against H. pylori. In vivo studies after treatment with SeCys and Ebs (500 ?g/kg/day) resulted in significant reduction in ROS production and inhibition of lipid peroxidation in gastric tissue. The antioxidant and anti-inflammatory activities of both the compounds were also confirmed by their ability to lower GSH reduction, to induce the expression of antioxidant genes such as GPx-4, and MnSOD and to suppress inflammatory genes namely COX-2, TNF-? and TGF-?. In addition, the immunomodulatory activity of both the compounds was evident by enhance of the CD4 levels and maintenance of the IgG, IL-6 and IL-10 levels. Persistent treatment (500 ?g/kg, for 28 days) with both the compounds showed considerable (p<0.05) ulcer healing property supporting its role in gastro protection. In conclusion, the results of our study suggest that both SeCys and Ebs possess broad spectrum of activities without any potential toxicity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1878-3252
pubmed:author
pubmed:copyrightInfo
Copyright © 2010 Elsevier GmbH. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
263-70
pubmed:meshHeading
pubmed-meshheading:20678908-Animals, pubmed-meshheading:20678908-Anti-Bacterial Agents, pubmed-meshheading:20678908-Anti-Ulcer Agents, pubmed-meshheading:20678908-Antioxidants, pubmed-meshheading:20678908-CD4-Positive T-Lymphocytes, pubmed-meshheading:20678908-CD8-Positive T-Lymphocytes, pubmed-meshheading:20678908-Helicobacter Infections, pubmed-meshheading:20678908-Helicobacter pylori, pubmed-meshheading:20678908-Immunoglobulin G, pubmed-meshheading:20678908-Interleukin-10, pubmed-meshheading:20678908-Interleukin-6, pubmed-meshheading:20678908-Naproxen, pubmed-meshheading:20678908-Organoselenium Compounds, pubmed-meshheading:20678908-Oxidative Stress, pubmed-meshheading:20678908-Rats, pubmed-meshheading:20678908-Rats, Wistar, pubmed-meshheading:20678908-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20678908-Stomach Ulcer, pubmed-meshheading:20678908-Transforming Growth Factor beta, pubmed-meshheading:20678908-Tumor Necrosis Factor-alpha
pubmed:year
2010
pubmed:articleTitle
Antibacterial and ulcer healing effects of organoselenium compounds in naproxen induced and Helicobacter pylori infected Wistar rat model.
pubmed:affiliation
Department of Physiology, Deccan College of Medical Sciences, Hyderabad, India.
pubmed:publicationType
Journal Article